OrthogenRx

Avanos Medical Inc. entered into a merger agreement to acquire OrthogenRx, Inc. for $130 million in cash at closing, plus up to $30 million in contingent consideration based on 2022 and 2023 net sales. The merger is expected to close in Q1 2022.